StimCardio Medical has completed an oversubscribed $30m Series A funding round to advance its non-invasive wearable, Rhyvive, for AF.The post...
Nuvation Bio is set to expand its pivotal Phase III SIGMA trial into Europe to evaluate safusidenib in patients with...
Dren Bio has secured $350m in an oversubscribed private financing round to advance its primary investigational therapy, dibotatug, through late-stage...
Empatica has launched WellPD, a FDA-cleared and CE-marked wearable system developed to monitor Parkinson's disease symptoms in home environments.The post...
Nacuity Pharmaceuticals has dosed the first patient in its global confirmatory Phase III SLO-RP Preserve study evaluating NPI-001 for RP...
Formation Bio has launched the Formation Bio Drug Development Accelerator Fund to broaden the company's clinical-stage medicines portfolio.The post Formation...
The US FDA has granted 510(k) clearance for Deep Reasoning AI’s NeuroDR, an AI software tool designed for neurovas CTA...
Vanda Pharmaceuticals has reported positive results from the Phase III clinical trial, Study 3601, assessing its Nereus oral therapy to...
Arrowhead Pharmaceuticals has received marketing authorisation from the UK MHRA for Redemplo as an adjunct to diet to cut triglyceride...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.